Indeed, the majority (80%) of ALCL patients bear a t(2;5) translocation which leads to the ectopic expression of a chimeric ALK tyrosine kinase, NPM-ALK also known as p80, since the chimeric protein weighs 80 kDa [15]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.